NLRP3 and heart failure: Moreover, we determined that the inhibitory effects of empagliflozin on the NLRP3 inflammasome are calcium-dependent.18 Taken together, these results suggest that a molecular target in the heart for the actions of the SGLT2is may be upstream of the NLRP3 inflammasome and is involved in promoting calcium-handling abnormalities in heart failure.